UnitedHealth Group (UNH) reported $112.03 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 0.4%. EPS of $6.38 for the same period compares to $4.08 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $110.12 billion, representing a surprise of +1.74%. The company delivered an EPS surprise of +29.15%, with the consensus EPS estimate being $4.94.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how UnitedHealth performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Operating Statistics - Medical Care Ratio: 86.7% versus 88.5% estimated by seven analysts on average. UnitedHealthcare Customer Profile - People Served - Total Commercial - Domestic: 29.92 million versus the five-analyst average estimate of 29.53 million. UnitedHealthcare Customer Profile - People Served - Commercial - Domestic - Risk-based: 7.66 million versus 7.26 million estimated by five analysts on average. UnitedHealthcare Customer Profile - People Served - Commercial - Domestic - Fee-based: 22.27 million versus 22.27 million estimated by five analysts on average. Revenues- Investment and other income: $1.22 billion versus the seven-analyst average estimate of $1.03 billion. The reported number represents a year-over-year change of +10.4%. Revenues- Products: $13.84 billion versus $13.69 billion estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +2% change. Revenues- Services: $10.02 billion versus $9.55 billion estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +10.8% change. Revenues- Premiums: $86.96 billion versus the seven-analyst average estimate of $86.21 billion. The reported number represents a year-over-year change of -1.1%. Revenues- Optum Insight: $5.4 billion versus $5.32 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +11.9% change. Revenues- Optum Rx: $38.29 billion versus $37.36 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a -0.4% change. Revenues- Optum Health: $23.47 billion compared to the $22.65 billion average estimate based on six analysts. The reported number represents a change of -6.9% year over year. Revenues- UnitedHealthcare- Total: $86.02 billion versus the six-analyst average estimate of $84.75 billion. The reported number represents a year-over-year change of -0.1%.View all Key Company Metrics for UnitedHealth here>>>
Shares of UnitedHealth have returned +4.8% over the past month versus the Zacks S&P 500 composite's +0.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).